De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis.
Arif Ali AwanBrian HuttonJohn HiltonSasha MazzarelloCatherine Van PoznakLisa VandermeerBrianne BotaCarol StoberMarta SienkiewiczDean FergussonRisa ShorrMark ClemonsPublished in: Breast cancer research and treatment (2019)
These data are supportive of de-escalation of zoledronate from onset for patients with bone metastases from breast cancer.